Stroke

Cardiovascular departments are playing a role in stroke interventions at numerous health systems, working as part of the stroke care team with neurologists, radiology and the emergency department. Stroke first has be be classified as ischemic or hemorrhagic. These have very different care pathways. Ischemic strokes are increasingly being treated with neurological-interventional therapy that includes catheter based mechanical thrombectomy to remove the clot. This is a more aggressive treatment compared to traditional IV administration of tissue plasminogen activator (tPA) thrombolytic therapy to dissolve the clot. Subarachnoid hemorrhage (SAH) and intracerebral hemorrhage (ICH) brain bleeds can also be treated in some cases stent flow diverters and embolization coils.

Effective, but not worth the cost: CEPD use during TAVR fails to make a significant difference
Cerebral embolic protection devices are proven to work. However, according to one cardiologist, they are still not consistently reducing stroke rates.
How the shape, size and location of calcified carotid plaques affect stroke risk
A new analysis provides further insight into factors affecting plaque stability and subsequent ischemic events
A closer look at world’s first TAVR patient treated with new cerebral embolic protection device
The device covers three vessels at once and can be deployed through the patient's TAVR access site. Researchers shared their first-in-human experience in JACC: Case Reports.
Cannabis is bad for the heart—should the risk be taken more seriously?
Use of the drug more than doubles a person's risk of dying from heart disease, according to a new analysis of 24 different studies. In a separate editorial, two physicians shared their concerns and highlighted the importance of discussing these risks with patients.
Extended CTA exams more than triple stroke detection
New research reveals that expanding CT angiography scans of the head and neck to capture the area at least 6 cm below the carina can significantly increase the detection of cardioaortic thrombi.

Terumo Interventional Systems launches dual-layer micromesh carotid stent after FDA approval

The dual-layer micromesh stent was designed with the flexibility of an open-cell stent and is available in multiple sizes.

MRI may not be suitable for spontaneous deep ICH

Study challenges use of MRI in spontaneous deep intracerebral hemorrhage

Spontaneous ICH carries a heightened risk of mortality, making locating its origin in a timely manner critical to outcomes.

Siemens Healthineers deploys its first mobile stroke unit in the US

The new device marks a “significant step forward” in American stroke care, the company contends.

Video of neurologist Lucy He, MD, with the Alaska Stoke Coalition, discussing how they use AI and CT to revolutionize stroke care in the state.

Revolutionizing stroke care in rural Alaska with AI and CT imaging

Lucy He, MD, a neurosurgeon with the Alaska Stroke Coalition, explains how the state created an AI-based alert system to streamline the timely imaging diagnosis and transfer of stroke patients across the largest and most rural U.S. state.

Video interview with Gregg Fonarow, MD, explaining the success of the AHA Get With The Guidelines-Stroke program, during AHA 2024.

Stroke care continues to evolve thanks to AI, cardiologists and more

Gregg Fonarow, MD, discussed the American Heart Association's stroke guidelines, the growing influence of AI and much more.

Heart patients, stroke survivors may live longer if they stay active after hospital discharge

Some patients struggle to bounce back after being hospitalized, but too much sedentary behavior could cause their health to get even worse. The research teams behind two separate studies are highlighting the importance of staying active.

PCI just as successful when patients have a history of TAVR—but there are some added risks

Strokes and bleeding complications are more likely when PCI patients have already undergone TAVR, according to a new analysis of ACC registry data.

High Lp(a) levels increase risk of repeat cardiovascular events—LDL drugs may help

Researchers evaluated data from more than 273,000 patients with a history of ASCVD, noting that higher Lp(a) levels are consistently linked to worse cardiovascular outcomes.

Stroke

Effective, but not worth the cost: CEPD use during TAVR fails to make a significant difference

How the shape, size and location of calcified carotid plaques affect stroke risk

A closer look at world’s first TAVR patient treated with new cerebral embolic protection device

Cannabis is bad for the heart—should the risk be taken more seriously?

Extended CTA exams more than triple stroke detection